Endocrine Abstracts

Introduction: Disruption of the hypothalamic dopaminergic inhibitory control of prolactin (PRL) secretion results in hyperprolactinaemia. We have previously shown in a large series of patients with non-functioning pituitary macroadenomas that serum PRL virtually never exceeds 2000 mU/l in the absence of PRL elevating medications. Current data on the effect of other sellar/parasellar masses are limited.Objective: To investigate the range of PRL values at ...

Background: Pituitary stalk compression by sellar/parasellar tumours [commonly non-functioning pituitary adenomas (NFA) or craniopharyngiomas (CR)] is one of the causes of hyperprolactinaemia. However, in such cases the upper limits of serum prolactin (PRL) are not clearly defined ('grey zone': 3000-6000 mU/L) causing confusion in the differential diagnosis between disconnection hyperprolactinaemia and prolactin-secreting adenomas.Objective: To investiga...

Background: A hydrocortisone day curve can be used to assess a patient's steroid replacement. However the need for venous samples requires patients to be admitted to hospital either over-night or as a day case and tablet times may vary compared to the patients' usual practice.Objective: The aim of this study was to determine whether patients could collect capillary or salivary cortisol at home and whether these collections were reproducible.<p class=...

Introduction: Pituitary adenomas causing acromegaly are immunocytochemically divided into 3 main groups: growth hormone (GH) cell (A), those with GH and prolactin (PRL) cell differentiation (B) and plurihormonal (C). Recent large series comparing the hormonal and imaging features of these tumours at diagnosis are lacking.Objectives: To investigate differences in the presenting hormonal and imaging data associated with the above groups of adenomas.<p ...

It has been suggested that primary medical treatment of patients with acromegaly using somatostatin analogues (SSA) is as effective at controlling GH levels as post-operative SSA therapy.We have carried out a prospective study in patients harbouring GH secreting macroadenomas to see, in a within-patient comparison, whether debulking pituitary surgery improved GH control on lanreotide compared with that obtained pre-operatively. Local Ethical Committee ap...

Background: Cushing’s disease (CD) may be associated with equivocal results on biochemical investigations.Aim: To evaluate the usefulness of dexamethazone suppression tests in the diagnostic work-up of CD.Patients and methods: Seventy patients with CD [median age 38 yrs(16–76), 53 females] presenting between 1976–2005 were studied. 24-hr urinary free cortisol (UFC), overnight (oDST) (1 mg at 23:00 h), low dose (LDDST...